Strata Skin Sciences, Inc.

SSKN Healthcare Medical Devices

Strata Skin Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $30.7 million, down 8.54% from fiscal 2024. In the quarter to December 2025, revenue fell 2.97%, EPS grew 111.5%, free cash flow fell 376.9% and total debt rose 1.03%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.00 0.00 NaN
Market cap
$1.0M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
5/9
Altman Z
−11.48
Beneish M
−3.33
Dividend safety
n/a
Dec '25 Sep '25 Jun '25 Mar '25 Older periods
Piotroski F-Score
5 3 3 5

+8 more TTM periods

ROE
(158.91%) (208.09%) (235.41%) (151.23%)
ROA
(19.13%) (31.27%) (32.83%) (24.63%)
ROIC
(28.40%) (63.41%) (65.80%) (52.10%)
Return on Tangible Assets
287.60% (126.06%) (137.81%) (89.71%)
Average Days of Receivables
49.00 41.28 44.69 54.36
Free Cash Flow per Share
(0.92) (0.78) (0.67) (0.16)
Free Cash Flow
(4.26) (3.51) (2.79) (0.67)
Other line items

Show all line items

Columns are period end dates